Rivian Down After R2 Reveal Disappoints Investors Today
Rivian’s shares fell roughly 5% after unveiling the R2, erasing prior gains as the market assesses the mass-market pr...
Find wealth growth strategies for working professionals that can enhance your financial situation. Learn how to maximize your earnings effectively.
24,306 articlesRivian’s shares fell roughly 5% after unveiling the R2, erasing prior gains as the market assesses the mass-market pr...
Looking for the best-performing tech stocks this week? This guide breaks down how to spot momentum, what to watch, an...
As OpenAI's ChatGPT racks up roughly 900 million weekly users, investors question whether Meta's embedded AI can tran...
A five-year AI infrastructure deal worth up to $27 billion between Nebius and Meta sparked a broad rally in lumentum,...
Missing the Medicare enrollment window can trigger a lifelong premium penalty and thousands in year-one costs. This r...
A concise look at the weapons that altered modern warfare and how investors are pricing defense tech in 2026.
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
LyondellBasell shares have surged about 74% year-to-date, trading near $75 as of mid-March 2026. The rally comes desp...
A surge in AI-focused crypto has investors weighing a $500 bet. This article breaks down how the technology works, th...
BTS returns with a high-profile comeback tour after completing military service, signaling a push to reclaim global p...
CrossCountry Mortgage enters the race to acquire Two Harbors, joining a competing all cash bid and heightening a batt...
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...